What's new in IL-12? Combination!

Autor: Vladimir Vainstein, Zoya Gluzman-Poltorak, Mark P. Rubinstein, Lena A. Basile, Chris E Lawrence
Rok vydání: 2015
Předmět:
Zdroj: Journal for Immunotherapy of Cancer
ISSN: 2051-1426
DOI: 10.1186/2051-1426-3-s2-p363
Popis: Meeting abstracts IL-12 is a heterodimeric, pro-inflammatory cytokine that enhances the cytotoxic activity of natural killer (NK) cells and cytotoxic CD8+ T-lymphocytes, and induces an IFN-α-dominated Th1 CD4+ T-lymphocyte response. IL-12 as an immunotherapeutic agent administered subcutaneously
Databáze: OpenAIRE
Externí odkaz: